Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
In this same population there was a non-statistically significant increase in DVT and stroke in the patients randomized to tamoxifen
doi: 10.1186/1476-4598-12-53
It should also be noted that, from a methodological perspective, the model used (Cox with stratification by cardiovascular risk class of the trials, i.e., SURPASS-4: high risk, and all others: low risk) requires various assumptions, including the homogeneity of the relative effect of tirzepatide treatment on MACE regardless of the baseline cardiovascular risk level of the patients
Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al
Most Common Side Effects: Nausea and vomiting Frequently reported, especially when increasing the dose
Treatments are usually spaced around a week apart, but your provider will tailor your treatment plan based on your symptoms and response
